Power doppler ultrasonography

PROCEDURE2 trials

Sponsors

GlaxoSmithKline, Novartis

Conditions

OsteoarthritisRheumatoid Arthritisgewrichtsaandoeningen, reumatische aandoeningen active psoriatic arthritis

Phase 3

A 52-week, multicenter study to assess the time course of response to secukinumab on joint inflammation using Power Doppler ultrasonography in patients with active psoriatic arthritis

Active, not recruitingNL-OMON47596

Novartisgewrichtsaandoeningen, reumatische aandoeningen active psoriatic arthritis

Start: 2017-10-24Target: 10Updated: 2024-02-28

Unknown Phase

A Study To Investigate Markers Of Inflammation In Rheumatoid Arthritis

CompletedNCT00242853

GlaxoSmithKlineOsteoarthritis, Rheumatoid Arthritis

Start: 2004-10-31Target: 48Updated: 2008-10-13